These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39167148)

  • 21. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers.
    Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS
    Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditions.
    Li X; Zhang H; Zhu X; Li C; Chen H; Liu J; Chen G; Wu M; Liu C; Shen Z; Niu J; Liu B; Ding Y
    Int J Clin Pharmacol Ther; 2018 Sep; 56(9):434-442. PubMed ID: 30049304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I crossover study of DNA-protein kinase inhibitor peposertib in healthy volunteers: Effect of food and pharmacokinetics of an oral suspension.
    Becker A; Krebs-Brown A; Vetter C; Reuter T; Rodriguez-Gutierrez A; You X; Lissy M
    Clin Transl Sci; 2023 Dec; 16(12):2628-2639. PubMed ID: 37905356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.
    Zomorodi K; Kankam M; Lu Y
    Clin Ther; 2019 Feb; 41(2):196-204. PubMed ID: 30598342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects.
    Wu J; Xu H; Li H; Ma L; Chen J; Yuan F; Sheng L; Liu C; Chen W; Li X
    Drug Des Devel Ther; 2023; 17():761-769. PubMed ID: 36925997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet
.
    Scheidel B; Maritz MA; Gschwind YJ; Steigerwald K; Guth V; Kovacs P; Rey H
    Int J Clin Pharmacol Ther; 2017 Nov; 55(11):881-890. PubMed ID: 28933336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
    Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
    BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase 1 Study to Assess the Relative Bioavailability, Food Effect, and Safety of a Tablet Formulation of GSK2838232, a Novel HIV Maturation Inhibitor in Healthy Participants After Single and Repeated Doses.
    Johnson M; Jewell RC; Gan J; Dumont E; Burns O; Johns BA
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):972-977. PubMed ID: 32558338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and Macrophage Inhibitory Cytokine-1 Pharmacodynamics of the Murine Double Minute 2 Inhibitor, Navtemadlin (KRT-232) in Fed and Fasted Healthy Subjects.
    Wong S; Krejsa C; Lee D; Harris A; Simard E; Wang X; Allard M; Podoll T; O'Reilly T; Slatter JG
    Clin Pharmacol Drug Dev; 2022 May; 11(5):640-653. PubMed ID: 35172043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Bioavailability Study of a New Orodispersible Formulation of Ibuprofen Versus Two Existing Oral Tablet Formulations in Healthy Male and Female Volunteers.
    Sugár D; Francombe D; da Silva T; Hanid S; Hutchings S
    Clin Ther; 2019 Aug; 41(8):1486-1498. PubMed ID: 31202508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.
    Weisler RH; Stark JG; Sikes C
    Clin Pharmacol Drug Dev; 2018 Feb; 7(2):160-167. PubMed ID: 28544344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects.
    Wang M; Wang M; Zhang Q; Zong S; Lv C
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension.
    Krishna G; Ma L; Martinho M; O'Mara E
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4196-201. PubMed ID: 22615291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects.
    Qian H; Wu X; Chen Q; Li T; Wang W; Jia J; Yu C; Li K; Sai Y; Su W; Liu Y
    Clin Ther; 2020 Sep; 42(9):1778-1786. PubMed ID: 32800383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
    Li W; Wang Y; Pei Y; Xia Y
    Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Safety, Bioavailability, and Pharmacokinetics of Oral Dexamethasone, 4-mg and 20-mg Tablets, in Healthy Volunteers Under Fasting and Fed Conditions: A Randomized Open-label, 3-way Crossover Study.
    Bashir Q; Acosta M
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):768-773. PubMed ID: 32900662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative Bioavailability and Food Effect Evaluation for 2 Tablet Formulations of Asciminib in a 2-Arm, Crossover, Randomized, Open-Label Study in Healthy Volunteers.
    Menssen HD; Quinlan M; Kemp C; Tian X
    Clin Pharmacol Drug Dev; 2019 Apr; 8(3):385-394. PubMed ID: 30059193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, Tolerability, and Pharmacokinetics of Valemetostat Tablets and the Effect of Food on Valemetostat Pharmacokinetics in Healthy Subjects: Two Phase 1 Studies.
    Tachibana M; Matsuki S; Toyama K; Maekawa Y; Fukae M; Shimizu T; Tsutsumi J; Shinohara S; Ishizuka H
    Clin Pharmacol Drug Dev; 2024 Jan; 13(1):77-86. PubMed ID: 37565616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials.
    van der Aar E; Desrivot J; Dupont S; Heckmann B; Fieuw A; Stutvoet S; Fagard L; Van de Wal K; Helmer E
    J Clin Pharmacol; 2019 Oct; 59(10):1366-1378. PubMed ID: 31012984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects.
    Harada A; Ikushima I; Haranaka M; Yanagihara A; Nakayama D
    Am J Cardiovasc Drugs; 2020 Jun; 20(3):249-258. PubMed ID: 31667735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.